Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yen-Wen Chen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unmet Need for Oral Corticosteroids Use and Exacerbations of Asthma in Primary Care in Taiwan

    by Yen-Wen Chen, Yi-Han Hsiao, Hsin-Kuo Ko, Tien-Hsin Jeng, Kang-Cheng Su, Diahn-Warng Perng

    Patients with asthma are treated in primary healthcare facilities (PHCFs) in Taiwan, where the asthma control status associated with acute exacerbation (AE) and use of oral corticosteroids (OCS) and short-acting β2-agonist (SABA) inhalers remains unclear. A cross-sectional, close-ended, face-to-face questionnaire survey invited board-certified physicians who treat adult asthma patients in PHCFs. The contents of the questionnaire included three parts: rescue OCS to treat AE, regular OCS for asthma control, and AE-related adverse outcomes. There were 445 out of 500 physicians who completed the questionnaire, with 61% of them being non-pulmonologists. A substantial proportion of asthma patients needed rescue OCS or regular OCS each month, or ≥3 canisters of SABA inhalers per year. Approximately 86% of physicians reported their patients with ≥2 AE-related unscheduled visits to clinics or emergency departments in the past year. A total of 41% of physicians reported their patients receiving intubation or intensive care in the past year. A total of 92% of physicians prescribed rescue OCS ≤ 40 mg/day. A total of 92% of physicians prescribed rescue OCS for a duration of ≤7 days for AEs. A total of 85% of physicians prescribed regular OCS ≤ 10 mg/day for asthma control. This is the first study to present the perceptions of asthma-treating physicians on the use of OCS in PHCFs. In summary, 31% of physicians reported ≥ 6% of their patients needed OCS for asthma control and 41% of physicians reported their patients with adverse outcomes in the past year. Thus, the need to improve asthma control in Taiwan is suggested by our study results.

  • Open Access

    Hyperbaric Oxygen Therapy for the Adjunctive Treatment of Stroke Associated with Post-Cardiac Surgery Due To Native-Valve Endocarditis Infected by Cutibacterium Acnes: A Case Report

    by Pei-Ku Chen, Tzu-Ting Kuo, Szu-Ying Lin, Jiang-Hwa Kao, Yen-Wen Chen

    Background Stroke is an uncommon but significant complication of cardiac surgery. Cutibacterium (previously known as Propionibacterium) rarely causes infective endocarditis (IE), accounting for approximately 0.3% of all IE cases. Hyperbaric oxygen therapy (HBOT), involving the administration of 100% oxygen at a pressure of > 1.4 atmospheres absolute, increases the partial pressure of oxygen; therefore, it is recommended as an adjunctive treatment for stroke and some infections. However, there are no data supporting HBOT as an adjunctive therapeutic option for ischemic stroke related to post-cardiac surgery due to IE caused by Cutibacterium acnes. Case presentation: This study reports the case of an 68-year-old male patient who underwent cardiac surgery for native-valve IE caused by C. acnes. He underwent HBOT on postoperative day 11 for the treatment of ischemic stroke. The patient received 20 sessions of HBOT along with 6-week antimicrobial treatment with ceftriaxone and rehabilitation programs. Conclusions We have summarized the patient’s successful recovery and our clinical experience regarding the use of HBOT in our clinical setting. HBOT is an effective adjunctive therapeutic option for ischemic stroke related to post-cardiac surgery due to IE caused by C. acnes.